MSB 2.67% $1.10 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-430

  1. 457 Posts.
    lightbulb Created with Sketch. 265
    Can you explain to me why you would have MSB ramp up production when there is no guarantee a product will be approved by FDA?
    Why should MSB take the risk? If more die, it is on FDA's head for not approving use in aGVHD (despite 9 to 1 experts wanting it approved).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.